首頁 > 市場調查報告書 > 食物/飲料

調味料

市場調查報告書

商品編碼

1455804

全球 FoS-Oligo 糖漿市場 - 2024-2031

Global FoS-Oligo Syrup Market - 2024-2031

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 209 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球 FoS-Oligo 糖漿市場在 2023 年達到 4.122 億美元，預計到 2031 年將達到 6.9301 億美元，在 2024-2031 年預測期間CAGR為 6.7%。

消費者對腸道健康的價值以及益生元在支持整體健康方面的作用的認知不斷提高，推動了對 FoS-Oligo 糖漿的需求。顧客正在尋找含有有用成分的商品，這些商品不僅是簡單的營養，還能提供額外的健康優勢。隨著人們對過量糖攝取對健康危害的擔憂增加，人們開始選擇天然和健康的甜味劑。

作為一種由植物材料製成的天然甜味劑，FoS-Oligo 糖漿被認為是普通糖的清潔標籤替代品。根據 ScienceDirect 的資料，在最近的一項全國營養調查中，美國約 25% 的兒童和超過 41% 的成年人表示食用含有低熱量甜味劑 (LCS) 的食品和飲料。這些數字表明，從 1999 年到 2022 年，兒童 LCS 消費量增加了 200%，成人 LCS 消費量增加了 54%。

FoS低聚醣漿市場的食品和飲料領域佔據了三分之一以上的佔有率。同樣，歐洲主導了 FoS 低聚醣漿市場，佔據了超過 1/3 的最大市場佔有率。隨著消費者優先考慮健康和保健，歐洲對 FoS-Oligo 糖漿的需求預計將繼續成長，推動益生元成分融入該地區的各種食品和飲料產品中。

動力學

與生活方式相關的健康問題盛行率上升

事實上，與生活方式選擇相關的健康問題日益普遍，極大地推動了 FoS-Oligo 糖漿的市場。肥胖、糖尿病和胃腸道疾病等與生活方式相關的健康問題的流行增加了消費者對 FoS-Oligo 糖漿等功能性食品成分和更好的食品選擇的需求。

在全球範圍內，肥胖率尤其顯著上升。 2023 年世界肥胖地圖集報告對全球超重和肥胖(BMI >=25kg/m2) 水平（整個地圖集也稱為高BMI）的估計表明，到2035 年，可能有超過40 億人受到影響，而這一數字超過26 億到 2020 年。這反映了世界人口比例從 2020 年的 38% 增加到 2035 年的 50% 以上（數字不包括 5 歲以下兒童）。

預計到 2035 年，僅肥胖 (BMI >=30kg/m2) 的盛行率就會從人口的 14% 上升至 24%，影響近 20 億成人、兒童和青少年。心臟病、2型糖尿病和一些惡性腫瘤等許多慢性疾病的危險因素，這一發展令人擔憂。

為了應對這些有關健康的趨勢，消費者對自己的健康變得更加積極主動，並正在尋找除了基本營養之外還具有功能性益處的食品和成分。 FoS-Oligo 糖漿作為一種益生元成分，擴大被納入各種食品和飲料產品中，以促進消化健康和整體福祉。

對功能性食品的需求不斷增加

事實上，FoS-Oligo 糖漿的市場很大程度上受到功能性食品需求不斷成長的推動。功能性食品通常含有生物活性化學物質，除了提供基本營養外，還可以支持健康和福祉。 FoS-Oligo 糖漿作為益生元成分屬於這一類別，因為它能夠促進良好腸道細菌的生長並增強消化健康。

健康意識的增強、飲食習慣的轉變以及對營養與健康之間聯繫的了解的增加，都促成了全球功能性食品市場近期的強勁成長。 FoS-Oligo 糖漿憑藉其益生元特性，擴大被納入各種功能性食品中，例如穀物、優格、飲料和烘焙食品，以增強其營養成分和促進健康的特性。

監管挑戰和標籤要求

標籤法規和監管障礙可能會為 FoS 低聚醣漿帶來嚴重的市場障礙。法規可能對製造商來說是一個障礙，特別是在涉及與 FoS-Oligo 糖漿等功能性成分相關的標籤法規和健康聲明時，儘管其主要目標是保護消費者並確保食品安全。

不同國家和地區監管要求不統一是主要障礙之一。對於在多個市場營運的生產商來說，這可能會導致複雜化，因為他們可能必須遵守管理包含 FoS-Oligo 糖漿的產品的標籤和行銷的不同監管法規。例如，「益生元」和「功能性食品」等術語在不同國家可能有不同的定義和監管，這可能會影響 FoS-Oligo 糖漿產品的標籤方式。

The demand for FoS-Oligo syrup has been driven by rising consumer awareness of the value of gut health and the part prebiotics play in supporting general well-being. Customers are looking for goods with useful ingredients that go beyond simple nourishment to provide additional health advantages. There is a movement toward natural and healthy sweetening options as worries about the health hazards of excessive sugar consumption increase.

As a natural sweetener made from plant materials, FoS-Oligo syrup is thought to be a cleaner-label substitute for regular sugars. According to ScienceDirect data, about 25 percent of children and more than 41 percent of adults in the U.S. reported consuming foods and beverages containing low-calorie sweeteners (LCS) in a recent nationwide nutritional survey. Those numbers represent a 200 percent increase in LCS consumption for children and a 54 percent jump for adults from 1999 to 2022.

The food and beverage segment in FoS-oligo syrup market accounts for over one-third of the share. Similarly, Europe dominates the FoS-oligo syrup market, capturing the largest market share of over 1/3rd. The demand for FoS-Oligo syrup in Europe is expected to continue growing as consumers prioritize health and wellness, driving the incorporation of prebiotic ingredients into a wide range of food and beverage products across the region.

Dynamics

Rise in Prevalence of Lifestyle-Related Health Issues

The market for FoS-Oligo syrup is, in fact, significantly driven by the rise in the prevalence of health problems associated with lifestyle choices. The prevalence of lifestyle-related health problems like obesity, diabetes, and gastrointestinal diseases has increased consumer demand for functional food components like FoS-Oligo syrup and better food options.

Globally, rates of obesity in particular have been rising significantly. World Obesity Atlas report of 2023 estimates for global levels of overweight and obesity (BMI >=25kg/m2), also referred to as high BMI throughout the Atlas, suggest that over 4 billion people may be affected by 2035, compared with over 2.6 billion in 2020. This reflects an increase from 38% of the world's population in 2020 to over 50% by 2035 (figures exclude children under 5 years old).

The prevalence of obesity (BMI >=30kg/m2) alone is anticipated to rise from 14% to 24% of the population over the same period, affecting nearly 2 billion adults, children, and adolescents by 2035. Given that obesity is a significant risk factor for many chronic illnesses, such as heart disease, type 2 diabetes, and some malignancies, this development is concerning.

In response to these concerning health trends, consumers are becoming more proactive about their health and are seeking out foods and ingredients that offer functional benefits beyond basic nutrition. FoS-Oligo syrup, being a prebiotic ingredient, is increasingly being incorporated into various food and beverage products marketed toward promoting digestive health and overall well-being.

Increasing Demand for Functional Foods

The market for FoS-Oligo syrup is, in fact, significantly driven by the rising demand for functional foods. Foods classified as functional often contain bioactive chemicals that support health and well-being in addition to basic nourishment. FoS-Oligo syrup fits into this category as a prebiotic component because of its capacity to promote the growth of good gut bacteria and enhance digestive health.

The increased health consciousness, shifting dietary habits, and increased knowledge of the connection between nutrition and health have all contributed to the recent strong rise of the worldwide functional food market. FoS-Oligo syrup, with its prebiotic properties, is increasingly being incorporated into a wide range of functional food products such as cereals, yogurt, beverages, and bakery items to enhance their nutritional profile and health-promoting properties.

Regulatory Challenges and Labeling Requirements

Labeling regulations and regulatory obstacles may pose serious market obstacles for FoS-oligo syrup. Regulations can be a barrier for manufacturers, especially when it comes to labeling regulations and health claims related to functional ingredients like FoS-Oligo syrup, even while its main goal is to protect consumers and assure food safety.

The absence of uniformity in regulatory requirements among various nations and areas is one of the main obstacles. For producers who operate in several markets, this can result in complications because they may have to adhere to different regulatory regulations governing the labeling and marketing of products that include FoS-Oligo syrup. Terms like "prebiotic" and "functional food," for instance, may be defined and regulated differently in different countries, which may affect how FoS-Oligo syrup products are labeled.

Segment Analysis

The global FoS-oligo syrup market is segmented based on origin, type, end-user, distribution channel and region.

The Surging Demand for Functional Ingredients in the Global Market

Some factors affect the market for FoS-Oligo syrup made from sucrose, but the main one is consumer preferences for natural and healthier sweeteners. Fos-oligo syrup made from sucrose is a naturally occurring source of fructo-oligosaccharides (FOS), which are produced by the enzymatic hydrolysis of sucrose and provide both sweetness and prebiotic advantages.

Manufacturers are also striving to produce the natural sweeteners to attract the consumers. In April 2021, Manus Bio, Inc. (Manus Bio), a leading U.S. manufacturer of sustainable natural ingredients, announced the launch of NutraSweet Natural, a plant-based sweetener with zero calories and 100% pure-tasting sweetness to enjoy in daily life. Manus Bio is paving the way for next-generation calorie reduction with a unique green technology for sourcing nature's sweetest ingredients while minimizing its environmental footprint.

The growing consumer awareness and worry about the harmful health implications of excessive sugar consumption, such as obesity, diabetes, and dental problems, is one important factor driving demand. Consequently, there is a growing movement to cut back on sugar consumption and look for better sweetener options. FoS-Oligo syrup, which is formed from sucrose, is a good option for producers who want to create goods with less sugar while keeping them sweet and useful.

Geographical Penetration

Increasing Trend of Gut Health and Overall Well-being among Europeans

According to UC Health gastroenterologist Hany Al-khedr, digestive diseases affect more than 300 million people in Europe and are linked to substantial economic costs. The incidence and prevalence of CD and UC are increasing in Europe, with an estimated 0.3% of the European population suffering from IBD, equalling 2.5-3 million persons. There is also a strong east/west gradient in the incidence of gastric cancer, which reflects the higher prevalence of H. pylori infection in eastern Europe and parts of southern Europe.

The demand for FoS-oligo syrup in Europe has been steadily increasing over recent years due to several factors. Firstly, there is a growing awareness among European consumers regarding the importance of gut health and the role of prebiotics in promoting it. FoS-oligo syrup, being a prebiotic ingredient, is sought after by health-conscious consumers who are looking for products that support digestive health and overall well-being.

The European market for FoS-Oligo syrup has also expanded as a result of initiatives and regulatory support for the use of prebiotics in food items. To stimulate consumer interest and demand, regulatory bodies like the European Food Safety Authority (EFSA) have approved health claims about the advantages of prebiotics. This gives manufacturers the chance to market products containing FoS-Oligo syrup with specific health claims.

COVID-19 Impact Analysis

The market for FoS-Oligo syrup was greatly influenced by the COVID-19 epidemic in several ways. Initially, difficulties locating raw materials and transporting completed goods were caused by disruptions in the global supply chain and logistics. The implementation of lockdown measures and movement limitations had an impact on customer purchase behavior, resulting in a shift towards essential products and a decrease in discretionary spending on functional food ingredients such as FoS-Oligo syrups.

On the other hand, demand for functional food products-including those with prebiotic components like FoS-Oligo syrups-grew as knowledge of the pandemic's health and immunity-boosting advantages increased. When customers looked for items that promoted gut health and general well-being, this trend-combined with an emphasis on preventative healthcare-stimulated market recovery and growth in some countries.

Russia-Ukraine War Impact Analysis

The conflict between Russia and Ukraine has caused major uncertainty and interruptions in a number of businesses, including the market for FoS-Oligo syrup. Given the importance of both Russia and Ukraine to the world's agriculture, any interruption in the supply chain-such as export limitations or logistical difficulties-may have an effect on where raw materials for the production of FoS-Oligo syrup are sourced.

The cost of producing and distributing FoS-Oligo syrups can also be impacted by changes in import-export laws and currency exchange rates brought on by geopolitical unrest and trade disruptions. Increased geopolitical tensions can also foster a climate of uncertainty that affects consumer and investor attitude and may reduce demand for non-essential food items like FoS-Oligo syrups.

By Origin

Sucrose-Derived
Inulin-Derived
Others

By Type

Short-chain FOS (scFOS)
Medium-chain FOS (mcFOS)
Long-chain FOS (mcFOS)

By End-User

Food and Beverage
Pharmaceuticals
Cosmetics & Personal Care
Industrial
Others

By Distribution Channel

Supermarkets/Hypermarkets
Online Retail
Specialty Stores
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In June 2022, Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, announced that it has completed the acquisition of Quantum Hi-Tech (Guangdong) Biological Co., Ltd (Quantum), a leading prebiotic dietary fiber business located in China. FOS and GOS fibers are highly complementary to their existing fiber portfolio and will allow offering a broader range of solutions to their customers across key markets.
In January 2022, Galam, a global manufacturer of specialty ingredients for the food and animal nutrition industries, launched a production plant for its prebiotic GOFOS. It is a short-chain fructooligosaccharide (sc-FOS) group of strong prebiotics, with scientific evidence suggesting daily consumption can bring about various health benefits in humans and animals. GOFOS is a soluble sc-FOS prebiotic fiber made by Galam.
In June 2020, global nutrition ingredients manufacturer Galam invested USD 20 million in the launch of two new fructooligosaccharides (FOS) production plants, each with a capacity to manufacture thousands of tons of the increasingly popular gut health-benefiting prebiotic fibers.

Competitive Landscape

The major global players in the market include BENEO GmbH, Sensus B.V., Tereos S.A., Cosucra Groupe Warcoing S.A., Quantum Hi-Tech (China) Biological Co., Ltd., Baolingbao Biology Co., Ltd., Ningbo J&S Botanics Inc., Cargill, Incorporated, Dupont de Nemours, Inc., and Ingredion Incorporated.

Why Purchase the Report?

To visualize the global FoS-oligo syrup market segmentation based on origin, type, end-user, distribution channel, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of FoS-oligo syrup market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global FoS-oligo syrup market report would provide approximately 70 tables, 66 figures, and 209 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet By Origin
3.2.Snippet by Type
3.3.Snippet by End-User
3.4.Snippet by Distribution Channel
3.5.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Rise in Prevalence of Lifestyle-Related Health Issues
  - 4.1.1.2.Increasing Demand for Functional Foods
- 4.1.2.Restraints
  - 4.1.2.1.Regulatory Challenges and Labeling Requirements
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Origin

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 7.1.2.Market Attractiveness Index, By Origin
7.2.Sucrose-Derived*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Inulin-Derived
7.4.Others

8.By Type

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2.Market Attractiveness Index, By Type
8.2.Short-chain FOS (scFOS)*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Medium-chain FOS (mcFOS)
8.4.Long-chain FOS (mcFOS)

9.By End-User

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2.Market Attractiveness Index, By End-User
9.2.Food & Beverage*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Pharmaceuticals
9.4.Cosmetics & Personal Care
9.5.Industrial
9.6.Others

10.By Distribution Channel

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2.Market Attractiveness Index, By Distribution Channel
10.2.Supermarkets/Hypermarkets*
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Online Retail
10.4.Specialty Stores
10.5.Others

11.By Region

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2.Market Attractiveness Index, By Region
11.2.North America
- 11.2.1.Introduction
- 11.2.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.6.1.U.S.
- 11.2.6.2.Canada
- 11.2.6.3.Mexico

11.3.Europe
- 11.3.1.Introduction
- 11.3.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.6.1.Germany
- 11.3.6.2.UK
- 11.3.6.3.France
- 11.3.6.4.Italy
- 11.3.6.5.Spain
- 11.3.6.6.Rest of Europe

11.4.South America
- 11.4.1.Introduction
- 11.4.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.6.1.Brazil
- 11.4.6.2.Argentina
- 11.4.6.3.Rest of South America

11.5.Asia-Pacific
- 11.5.1.Introduction
- 11.5.2.Key Region-Specific Dynamics
- 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1.China
  - 11.5.7.2.India
  - 11.5.7.3.Japan
  - 11.5.7.4.Australia
  - 11.5.7.5.Rest of Asia-Pacific
11.6.Middle East and Africa
- 11.6.1.Introduction
- 11.6.2.Key Region-Specific Dynamics
- 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

12.1.Competitive Scenario
12.2.Market Positioning/Share Analysis
12.3.Mergers and Acquisitions Analysis

13.Company Profiles

13.1.ADM BENEO GmbH*
- 13.1.1.Company Overview
- 13.1.2.Product Portfolio and Description
- 13.1.3.Financial Overview
- 13.1.4.Key Developments
13.2.Sensus B.V.
13.3.Tereos S.A.
13.4.Cosucra Groupe Warcoing S.A.
13.5.Quantum Hi-Tech (China) Biological Co., Ltd.
13.6.Baolingbao Biology Co., Ltd.
13.7.Ningbo J&S Botanics Inc.
13.8.Cargill, Incorporated
13.9.Dupont de Nemours, Inc.
13.10.Ingredion Incorporated

LIST NOT EXHAUSTIVE